Here's Why Revvity (RVTY) is a Strong Momentum Stock

Company Overview - Revvity, Inc. is headquartered in Waltham, MA, and provides scientific instruments, consumables, and services to various markets including pharmaceutical, biomedical, environmental testing, chemical, and general industrial sectors. The company was previously known as PerkinElmer until March 2023 [11]. Recent Developments - In March 2023, Revvity completed the sale of its Applied, Food and Enterprise Services (AES) businesses to New Mountain Capital for up to $2.45 billion. Following this divestiture, the company changed its name to Revvity effective April 26, 2023, and its ticker symbol changed from PKI to RVTY on May 16, 2023 [11]. Stock Performance - Revvity (RVTY) currently holds a 3 (Hold) rating on the Zacks Rank, with a VGM Score of B. The stock has a Momentum Style Score of A, and shares have increased by 4.9% over the past four weeks [12]. - Two analysts have revised their earnings estimates upwards for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.02 to $5.33 per share. Revvity has an average earnings surprise of +4.1% [12]. Investment Consideration - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Revvity is recommended to be on investors' short list for potential investment opportunities [13].